Recent Posts

Supreme Court Questions Limits On Use Of Prescription Data
Posted on 27 Apr 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court cast doubt Tuesday on efforts by states to limit drug manufacturers' use of information about the prescription drugs that doctors like to prescribe. The court took up a dispute between the state of Vermont... Read More

Supreme Court: No Third-Party Beneficiary Lawsuits Challenging Drug Prices
Posted on 29 Mar 2011 by Cheryl Keely

WASHINGTON, D.C. -- (Mealey's) The U.S. Supreme Court on March 29 reversed a Ninth Circuit U.S. Court of Appeals decision in finding that a federal regulation imposing ceilings on prices drug manufacturers may charge for medications sold to health... Read More

Brand-Name Pharmaceutical Companies Can Be Liable to Generic Drug Users for Recklessly Providing Inadequate Warnings on Brand-Name Drugs
Posted on 2 Apr 2018 by Gabriela Nolen

Chief Justice Ralph D. Gants of the Supreme Judicial Court of Massachusetts wrote for the Court on March 16, 2018 that a generic drug user’s negligence claim against Merck had been properly dismissed by the Judge Kenneth J. Fishman of the Middlesex... Read More

FDA Removes More Than 500 Unapproved Cough, Cold And Allergy Drugs
Posted on 2 Mar 2011 by Tom Moylan

ROCKVILLE, Md. - (Mealey's) The Food and Drug Administration on March 2 announced that it is requiring drug manufacturers to take more than 500 prescription cough, cold and allergy drugs off the market because they are unapproved. The drugs... Read More